News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Guilherme Nader Marta: Our Review On the PI3K/Akt-targeted Agents
Photo taken from Photo from Guilherme Nader Marta/X
Jun 14, 2024, 03:24

Guilherme Nader Marta: Our Review On the PI3K/Akt-targeted Agents

Guilherme Nader Marta, Oncology Fellow at Jules Bordet Institute, shared on X:

“PI3K/Akt-targeted agents entered clinical practice & may soon bring precision oncology to 1st line of Tx for ER+ breast cancer

Out in Critical Reviews in Oncology Hematology (CROH) our review on the activity, biomarkers & toxicities w/ these agents & next steps in the field”

Guilherme Nader Marta: Our Review On the PI3K/Akt-targeted Agents Guilherme Nader Marta: Our Review On the PI3K/Akt-targeted Agents

Read further.
Source: Guilherme Nader Marta/X

activity biomarkers cancer clinical practice Critical Reviews in Oncology Hematology (CROH) ER+ breast cancer Guilherme Nader Marta Jules Bordet Institute next steps in the field OncoDaily Oncology oncology fellow PI3K/Akt-targeted agents Precision Oncology review article toxicities
Special Coverage
Science
Dec 21, 2024, 13:18
Ruzanna Papyan: The Impact of Telemedicine on Improving Soft Tissue and Bone Tumor Management in Armenia
Science
Dec 21, 2024, 13:12
Myeloma Paper of the Day, December 21st, suggested by Robert Orlowski
Blog
Dec 21, 2024, 13:06
Varsha Gupta: Fertility preservation causes no significant delay in cancer treatment initiation and outcomes
Cancer Types
Dec 21, 2024, 13:05
Esophageal Cancer: Symptoms, Causes, Stages, Diagnosis & Treatment
Insight
Dec 21, 2024, 12:45
Practical treatment strategies and novel therapies for HR positive/HER2 negative advanced breast cancer
Insight
Dec 21, 2024, 12:39
Heterogeneity of Residual Disease After Neoadjuvant Systemic Therapy in Breast Cancer
Blog
Dec 21, 2024, 12:18
NCI Symposium on Translational Technology for Global Health
Blog
Dec 21, 2024, 12:14
Paolo Tarantino: Ending of a terrific 3-year cycle of PhD at The University of Milan
Blog
Dec 21, 2024, 11:52
Gevorg Tamamyan's first message as New POEM President
Blog
Dec 21, 2024, 11:30
Kyaw Thein: Tissue-Agnostic Drug Development in Cancer
Dialogues
Dec 21, 2024, 11:29
Beyond the Cancer Diagnosis: Dialogue with Marianne Arab, Hosted by Adrian Pogacian
Blog
Dec 21, 2024, 11:27
Aleix Prat: Carlos Fernandez de Larrea has been appointed as a Professor at the University of Barcelona